| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.978 | 0.003 | 0.984 | Toll-Like receptor agonist | 0.984 0.003 DBMET03678 0.967 0.004 DBMET03679 0.926 0.004 DBMET03680 | DBMET03678 | |
| 0.977 | 0.003 | 0.983 | Toll-Like receptor 7 agonist | 0.983 0.003 DBMET03678 0.966 0.003 DBMET03679 0.926 0.004 DBMET03680 | DBMET03678 | |
| 0.746 | 0.003 | 0.746 | Cholinergic antagonist | 0.709 0.003 DBMET03678 0.738 0.003 DBMET03679 0.34 0.011 DBMET03680 | ||
| 0.743 | 0.003 | 0.743 | Acetylcholine antagonist | 0.702 0.003 DBMET03678 0.735 0.003 DBMET03679 0.302 0.014 DBMET03680 | ||
| 0.691 | 0.003 | 0.692 | Acetylcholine muscarinic antagonist | 0.64 0.003 DBMET03678 0.692 0.003 DBMET03679 0.342 0.006 DBMET03680 | DBMET03679 | |
| 0.649 | 0.004 | 0.694 | Bronchodilator | 0.694 0.004 DBMET03678 0.593 0.004 DBMET03679 0.295 0.009 DBMET03680 | DBMET03678 | |
| 0.556 | 0.004 | 0.59 | Acetylcholine M1 receptor antagonist | 0.59 0.003 DBMET03678 0.555 0.004 DBMET03679 0.244 0.027 DBMET03680 | DBMET03678 | |
| 0.547 | 0.002 | 0.596 | Acetylcholine M3 receptor antagonist | 0.472 0.003 DBMET03678 0.596 0.002 DBMET03679 0.107 0.016 DBMET03680 | DBMET03679 | |
| 0.465 | 0.028 | 0.593 | Spasmolytic | 0.421 0.036 DBMET03678 0.491 0.024 DBMET03679 0.593 0.014 DBMET03680 | DBMET03680 | |
| 0.337 | 0.004 | 0.413 | Acetylcholine M2 receptor antagonist | 0.413 0.004 DBMET03678 0.328 0.004 DBMET03679 | DBMET03678 | |
| 0.277 | 0.023 | 0.277 | Cytidine deaminase inhibitor | 0.231 0.035 DBMET03678 0.227 0.036 DBMET03679 | ||
| 0.315 | 0.082 | 0.604 | Cholesterol antagonist | 0.229 0.141 DBMET03678 0.341 0.068 DBMET03679 0.604 0.018 DBMET03680 | DBMET03680 | |
| 0.19 | 0.004 | 0.19 | Substance P antagonist | 0.068 0.009 DBMET03678 0.126 0.005 DBMET03679 0.037 0.03 DBMET03680 | ||
| 0.231 | 0.048 | 0.243 | Growth hormone agonist | 0.243 0.045 DBMET03679 | DBMET03679 | |
| 0.171 | 0.017 | 0.171 | Sphingomyelinase inhibitor | 0.123 0.039 DBMET03678 0.142 0.028 DBMET03679 0.124 0.038 DBMET03680 | ||
| 0.189 | 0.057 | 0.198 | Antipruritic | 0.198 0.05 DBMET03678 0.179 0.065 DBMET03679 | DBMET03678 | |
| 0.121 | 0.008 | 0.121 | Neurokinin antagonist | 0.051 0.033 DBMET03678 0.08 0.017 DBMET03679 | ||
| 0.116 | 0.005 | 0.116 | Neurokinin 1 antagonist | 0.043 0.025 DBMET03678 0.078 0.01 DBMET03679 | ||
| 0.15 | 0.042 | 0.156 | Ca2+-transporting ATPase inhibitor | 0.156 0.029 DBMET03678 0.144 0.06 DBMET03679 0.138 0.079 DBMET03680 | DBMET03678 | |
| 0.128 | 0.027 | 0.154 | Acetylcholine nicotinic antagonist | 0.154 0.019 DBMET03678 0.109 0.034 DBMET03679 | DBMET03678 | |
| 0.151 | 0.054 | 0.24 | Alpha-N-acetylglucosaminidase inhibitor | 0.24 0.024 DBMET03678 0.171 0.045 DBMET03680 | DBMET03678 | |
| 0.132 | 0.041 | 0.132 | Nav1.1 sodium channel blocker | 0.132 0.041 DBMET03679 | ||
| 0.142 | 0.053 | 0.142 | Anesthetic local | 0.14 0.054 DBMET03678 0.127 0.062 DBMET03679 | ||
| 0.088 | 0.006 | 0.109 | Beta 2 adrenoreceptor agonist | 0.078 0.01 DBMET03678 0.109 0.004 DBMET03679 | DBMET03679 | |
| 0.117 | 0.036 | 0.117 | Acetylcholine M3 receptor agonist | 0.092 0.05 DBMET03678 0.079 0.062 DBMET03679 | ||
| 0.078 | 0.005 | 0.078 | GABA uptake inhibitor | 0.049 0.016 DBMET03678 0.057 0.011 DBMET03679 | ||
| 0.11 | 0.039 | 0.165 | Triose-phosphate isomerase inhibitor | 0.12 0.032 DBMET03678 0.088 0.063 DBMET03679 0.165 0.016 DBMET03680 | DBMET03680 | |
| 0.095 | 0.041 | 0.136 | Adrenaline agonist | 0.087 0.048 DBMET03678 0.136 0.019 DBMET03679 | DBMET03679 | |
| 0.143 | 0.09 | 0.166 | Sigma receptor agonist | 0.121 0.113 DBMET03678 0.166 0.075 DBMET03679 | DBMET03679 | |
| 0.182 | 0.13 | 0.182 | RNA-directed DNA polymerase inhibitor | 0.18 0.132 DBMET03678 0.178 0.136 DBMET03679 | ||
| 0.195 | 0.145 | 0.245 | Tyrosine 3 hydroxylase inhibitor | 0.245 0.073 DBMET03678 0.234 0.085 DBMET03679 | DBMET03678 | |
| 0.085 | 0.042 | 0.092 | Acetylcholine M4 receptor antagonist | 0.092 0.035 DBMET03678 | DBMET03678 | |
| 0.079 | 0.04 | 0.109 | Glycine receptor agonist | 0.109 0.016 DBMET03678 0.071 0.052 DBMET03679 | DBMET03678 | |
| 0.062 | 0.025 | 0.105 | Alpha-mannosidase inhibitor | 0.066 0.02 DBMET03678 0.053 0.037 DBMET03679 0.105 0.006 DBMET03680 | DBMET03680 | |
| 0.053 | 0.018 | 0.053 | Guanylate cyclase inhibitor | 0.04 0.033 DBMET03678 0.04 0.034 DBMET03679 0.049 0.022 DBMET03680 | ||
| 0.129 | 0.096 | 0.138 | MAP3K9 inhibitor | 0.138 0.081 DBMET03678 0.126 0.101 DBMET03679 | DBMET03678 | |
| 0.042 | 0.014 | 0.042 | Ceramide glucosyltransferase inhibitor | 0.038 0.02 DBMET03679 0.035 0.026 DBMET03680 | ||
| 0.048 | 0.021 | 0.058 | Beta adrenoreceptor agonist | 0.045 0.03 DBMET03678 0.058 0.009 DBMET03679 | DBMET03679 | |
| 0.049 | 0.026 | 0.105 | Mannosidase inhibitor | 0.053 0.022 DBMET03678 0.041 0.039 DBMET03679 0.105 0.005 DBMET03680 | DBMET03680 | |
| 0.071 | 0.05 | 0.071 | Calcium channel L-type blocker | |||
| 0.077 | 0.057 | 0.081 | Interferon agonist | 0.071 0.068 DBMET03678 0.081 0.05 DBMET03680 | DBMET03680 | |
| 0.259 | 0.243 | 0.307 | Caspase 9 stimulant | 0.275 0.222 DBMET03678 0.307 0.186 DBMET03679 0.282 0.214 DBMET03680 | DBMET03679 | |
| 0.054 | 0.041 | 0.054 | Sphingosine kinase 2 inhibitor | 0.054 0.04 DBMET03679 | ||
| 0.208 | 0.201 | 0.208 | Calcium channel activator | |||
| 0.055 | 0.049 | 0.055 | Sphingosine kinase inhibitor | 0.055 0.05 DBMET03679 | ||
| 0.025 | 0.023 | 0.029 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.029 0.012 DBMET03678 | DBMET03678 | |
| 0.062 | 0.06 | 0.062 | Glutamate (mGluR6) antagonist | |||
| 0.052 | 0.053 | 0.101 | Carbamoyl phosphate synthetase inhibitor | 0.101 0.02 DBMET03678 | DBMET03678 | |
| 0.078 | 0.081 | 0.134 | HIV-1 integrase (Overall Integration) inhibitor | 0.134 0.032 DBMET03678 | DBMET03678 | |
| 0.042 | 0.046 | 0.052 | Glucose-6-phosphate isomerase inhibitor | 0.052 0.026 DBMET03678 0.049 0.031 DBMET03680 | DBMET03678 | |
| 0.13 | 0.135 | 0.195 | Psychostimulant | 0.195 0.083 DBMET03678 | DBMET03678 | |
| 0.021 | 0.03 | 0.024 | 5 Hydroxytryptamine 4 agonist | 0.024 0.018 DBMET03678 | DBMET03678 | |
| 0.107 | 0.125 | 0.117 | Vanilloid 1 agonist | 0.117 0.096 DBMET03679 | DBMET03679 | |
| 0.032 | 0.053 | 0.042 | Thymidine kinase inhibitor | 0.042 0.027 DBMET03678 | DBMET03678 | |
| 0.042 | 0.067 | 0.051 | Nicotinic receptor alpha7 subunit antagonist | 0.051 0.043 DBMET03678 | DBMET03678 | |
| 0.073 | 0.103 | 0.138 | UDP-glucose 4-epimerase inhibitor | 0.099 0.062 DBMET03678 0.138 0.033 DBMET03680 | DBMET03680 | |
| 0.045 | 0.077 | 0.083 | Phosphofructokinase-1 inhibitor | 0.07 0.047 DBMET03678 0.083 0.04 DBMET03680 | DBMET03680 | |
| 0.126 | 0.166 | 0.18 | Succinate dehydrogenase inhibitor | 0.18 0.068 DBMET03678 | DBMET03678 | |
| 0.068 | 0.109 | 0.08 | Interleukin 5 antagonist | 0.08 0.073 DBMET03680 | DBMET03680 | |
| 0.106 | 0.149 | 0.17 | Arachidonic acid antagonist | 0.17 0.066 DBMET03678 | DBMET03678 | |
| 0.017 | 0.061 | 0.062 | Sodium/glucose cotransporter inhibitor | 0.062 0.004 DBMET03680 | DBMET03680 | |
| 0.034 | 0.083 | 0.05 | Aconitate hydratase inhibitor | 0.05 0.039 DBMET03678 | DBMET03678 | |
| 0.068 | 0.119 | 0.115 | GABA C receptor agonist | 0.115 0.053 DBMET03678 | DBMET03678 | |
| 0.096 | 0.148 | 0.234 | Cell wall synthesis inhibitor | 0.132 0.084 DBMET03678 0.234 0.019 DBMET03680 | DBMET03680 | |
| 0.065 | 0.118 | 0.094 | NADH dehydrogenase inhibitor | 0.084 0.067 DBMET03678 0.094 0.051 DBMET03680 | DBMET03680 | |
| 0.057 | 0.11 | 0.083 | Opioid kappa receptor antagonist | 0.083 0.054 DBMET03679 | DBMET03679 | |
| 0.011 | 0.066 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.01 DBMET03680 | DBMET03680 | |
| 0.069 | 0.125 | 0.091 | Anabolic | 0.091 0.076 DBMET03678 | DBMET03678 | |
| 0.062 | 0.118 | 0.178 | Mediator release inhibitor | 0.178 0.019 DBMET03680 | DBMET03680 | |
| 0.121 | 0.183 | 0.141 | Phospholipase C inhibitor | 0.141 0.126 DBMET03678 | DBMET03678 | |
| 0.042 | 0.106 | 0.084 | Na+ K+ transporting ATPase inhibitor | 0.084 0.047 DBMET03680 | DBMET03680 | |
| 0.018 | 0.082 | 0.027 | Estrogen-related receptor gamma antagonist | 0.027 0.022 DBMET03678 | DBMET03678 | |
| 0.104 | 0.168 | 0.139 | Adenylate cyclase stimulant | 0.139 0.083 DBMET03678 | DBMET03678 | |
| 0.159 | 0.226 | 0.334 | Vasodilator, coronary | 0.334 0.064 DBMET03680 | DBMET03680 | |
| 0.062 | 0.132 | 0.215 | Expectorant | 0.215 0.018 DBMET03680 | DBMET03680 | |
| 0.153 | 0.223 | 0.188 | Neuropeptide Y2 antagonist | 0.188 0.143 DBMET03678 | DBMET03678 | |
| 0.01 | 0.093 | 0.051 | Sodium/glucose cotransporter 2 inhibitor | 0.051 0.006 DBMET03680 | DBMET03680 | |
| 0.147 | 0.235 | 0.169 | 5 Hydroxytryptamine 3E antagonist | 0.169 0.138 DBMET03678 | DBMET03678 | |
| 0.16 | 0.249 | 0.288 | Sodium/bile acid cotransporter inhibitor | 0.288 0.091 DBMET03678 0.248 0.13 DBMET03679 | DBMET03678 | |
| 0.161 | 0.252 | 0.191 | 5 Hydroxytryptamine uptake stimulant | 0.191 0.171 DBMET03678 | DBMET03678 | |
| 0.062 | 0.166 | 0.08 | Estrogen-related receptor beta agonist | 0.08 0.067 DBMET03678 | DBMET03678 | |
| 0.023 | 0.131 | 0.054 | Alcohol oxidase inhibitor | 0.054 0.04 DBMET03678 | DBMET03678 | |
| 0.097 | 0.207 | 0.177 | Interferon gamma antagonist | 0.177 0.052 DBMET03680 | DBMET03680 | |
| 0.099 | 0.209 | 0.437 | Aldehyde oxidase inhibitor | 0.437 0.042 DBMET03678 0.153 0.136 DBMET03679 | DBMET03678 | |
| 0.077 | 0.191 | 0.16 | Protein kinase stimulant | 0.16 0.062 DBMET03680 | DBMET03680 | |
| 0.059 | 0.176 | 0.097 | GABA C receptor antagonist | 0.097 0.083 DBMET03678 | DBMET03678 | |
| 0.044 | 0.162 | 0.076 | Opioid antagonist | 0.076 0.074 DBMET03679 | DBMET03679 | |
| 0.049 | 0.171 | 0.104 | Creatine kinase inhibitor | 0.104 0.056 DBMET03678 | DBMET03678 | |
| 0.104 | 0.229 | 0.184 | Neurotrophic factor enhancer | 0.184 0.093 DBMET03678 | DBMET03678 | |
| 0.065 | 0.193 | 0.217 | Cyclooxygenase 3 inhibitor | 0.217 0.014 DBMET03680 | DBMET03680 | |
| 0.034 | 0.161 | 0.064 | Aminopeptidase I inhibitor | 0.064 0.061 DBMET03678 | DBMET03678 | |
| 0.02 | 0.148 | 0.064 | Antibiotic Aminoglycoside-like | 0.064 0.007 DBMET03680 | DBMET03680 | |
| 0.04 | 0.169 | 0.061 | Lipocortins synthesis agonist | 0.061 0.034 DBMET03680 | DBMET03680 | |
| 0.179 | 0.314 | 0.292 | Calcium channel L-type activator | 0.292 0.164 DBMET03679 | DBMET03679 | |
| 0.149 | 0.29 | 0.226 | GABA C receptor rho-3 antagonist | 0.226 0.178 DBMET03678 | DBMET03678 | |
| 0.031 | 0.179 | 0.069 | Phospholipase D inhibitor | 0.069 0.055 DBMET03678 | DBMET03678 | |
| 0.137 | 0.306 | 0.367 | Apoptosis antagonist | 0.367 0.049 DBMET03680 | DBMET03680 | |
| 0.04 | 0.219 | 0.111 | ATPase (Vacuolar H+) inhibitor | 0.111 0.027 DBMET03680 | DBMET03680 | |
| 0.114 | 0.293 | 0.222 | DNA synthesis inhibitor | 0.222 0.092 DBMET03680 | DBMET03680 | |
| 0.08 | 0.264 | 0.381 | Immunostimulant | 0.381 0.055 DBMET03680 | DBMET03680 | |
| 0.049 | 0.237 | 0.118 | Transcription factor NF kappa B stimulant | 0.118 0.026 DBMET03680 | DBMET03680 | |
| 0.197 | 0.388 | 0.28 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.28 0.24 DBMET03678 | DBMET03678 | |
| 0.07 | 0.274 | 0.194 | Interleukin agonist | 0.167 0.152 DBMET03678 0.194 0.126 DBMET03680 | DBMET03680 | |
| 0.076 | 0.28 | 0.15 | Melanin inhibitor | 0.15 0.082 DBMET03680 | DBMET03680 | |
| 0.069 | 0.309 | 0.138 | DNA repair enzyme inhibitor | 0.138 0.044 DBMET03680 | DBMET03680 | |
| 0.03 | 0.273 | 0.055 | Adenine nucleotide translocase inhibitor | 0.055 0.041 DBMET03680 | DBMET03680 | |
| 0.087 | 0.339 | 0.173 | Superoxide dismutase inhibitor | 0.173 0.15 DBMET03678 | DBMET03678 | |
| 0.098 | 0.351 | 0.457 | Antithrombotic | 0.457 0.036 DBMET03680 | DBMET03680 | |
| 0.039 | 0.298 | 0.216 | Lipid peroxidase inhibitor | 0.216 0.035 DBMET03680 | DBMET03680 | |
| 0.043 | 0.315 | 0.144 | Toll-Like receptor 4 antagonist | 0.144 0.025 DBMET03680 | DBMET03680 | |
| 0.038 | 0.314 | 0.184 | Amylase inhibitor | 0.184 0.05 DBMET03680 | DBMET03680 | |
| 0.143 | 0.421 | 0.258 | 5 Hydroxytryptamine release inhibitor | 0.258 0.217 DBMET03678 | DBMET03678 | |
| 0.015 | 0.305 | 0.096 | Monophenol monooxygenase inhibitor | 0.096 0.079 DBMET03680 | DBMET03680 | |
| 0.012 | 0.303 | 0.303 | Selectin antagonist | 0.303 0.005 DBMET03680 | DBMET03680 | |
| 0.06 | 0.351 | 0.335 | Hepatoprotectant | 0.335 0.021 DBMET03680 | DBMET03680 | |
| 0.019 | 0.317 | 0.069 | Glucose-6-phosphate translocase inhibitor | 0.069 0.017 DBMET03680 | DBMET03680 | |
| 0.04 | 0.358 | 0.533 | Angiogenesis stimulant | 0.533 0.01 DBMET03680 | DBMET03680 | |
| 0.092 | 0.417 | 0.55 | Antibacterial | 0.55 0.029 DBMET03680 | DBMET03680 | |
| 0.018 | 0.344 | 0.061 | Heparanase inhibitor | 0.061 0.022 DBMET03680 | DBMET03680 | |
| 0.044 | 0.379 | 0.194 | Hypolipemic | 0.194 0.099 DBMET03680 | DBMET03680 | |
| 0.106 | 0.452 | 0.353 | Interleukin 2 agonist | 0.218 0.16 DBMET03678 0.353 0.044 DBMET03680 | DBMET03680 | |
| 0.049 | 0.409 | 0.191 | Hemostatic | 0.191 0.036 DBMET03680 | DBMET03680 | |
| 0.043 | 0.42 | 0.28 | Nitric oxide antagonist | 0.28 0.044 DBMET03680 | DBMET03680 | |
| 0.055 | 0.44 | 0.144 | ATPase inhibitor | 0.144 0.111 DBMET03680 | DBMET03680 | |
| 0.012 | 0.418 | 0.027 | Toll-Like receptor 4 agonist | 0.027 0.017 DBMET03680 | DBMET03680 | |
| 0.024 | 0.433 | 0.099 | Beta glucuronidase inhibitor | 0.099 0.071 DBMET03680 | DBMET03680 | |
| 0.006 | 0.435 | 0.028 | Protein 30S ribosomal subunit inhibitor | 0.028 0.014 DBMET03680 | DBMET03680 | |
| 0.089 | 0.52 | 0.332 | Peptidyltransferase inhibitor | 0.332 0.015 DBMET03680 | DBMET03680 | |
| 0.005 | 0.436 | 0.108 | Antineoplastic antibiotic | 0.108 0.043 DBMET03680 | DBMET03680 | |
| 0.075 | 0.546 | 0.441 | Apoptosis agonist | 0.441 0.095 DBMET03680 | DBMET03680 | |
| 0.031 | 0.536 | 0.203 | Vasodilator | 0.203 0.102 DBMET03680 | DBMET03680 | |
| 0.03 | 0.541 | 0.435 | Antioxidant | 0.435 0.029 DBMET03680 | DBMET03680 | |
| 0.01 | 0.528 | 0.077 | Protein 50S ribosomal subunit inhibitor | 0.077 0.021 DBMET03680 | DBMET03680 | |
| 0.011 | 0.557 | 0.118 | Topoisomerase I inhibitor | 0.118 0.057 DBMET03680 | DBMET03680 | |
| 0.025 | 0.602 | 0.254 | Transcription factor NF kappa B inhibitor | 0.254 0.124 DBMET03680 | DBMET03680 | |
| 0.034 | 0.615 | 0.367 | Immunosuppressant | 0.367 0.078 DBMET03680 | DBMET03680 | |
| 0.017 | 0.611 | 0.101 | Estrogen antagonist | 0.101 0.097 DBMET03679 | DBMET03679 | |
| 0.017 | 0.646 | 0.13 | Cell adhesion inhibitor | 0.13 0.059 DBMET03680 | DBMET03680 | |
| 0.03 | 0.704 | 0.464 | Hypoglycemic | 0.464 0.019 DBMET03680 | DBMET03680 | |
| 0.011 | 0.696 | 0.371 | Free radical scavenger | 0.371 0.034 DBMET03680 | DBMET03680 | |
| 0.015 | 0.718 | 0.143 | Insulin secretagoues | 0.143 0.082 DBMET03680 | DBMET03680 | |
| 0.009 | 0.773 | 0.182 | Thrombolytic | 0.182 0.061 DBMET03680 | DBMET03680 | |
| 0.058 | 0.826 | 0.122 | CC chemokine 6 receptor antagonist | 0.122 0.105 DBMET03680 | DBMET03680 | |
| 0.019 | 0.834 | 0.535 | Antiinflammatory | 0.535 0.074 DBMET03680 | DBMET03680 | |
| 0.024 | 0.865 | 0.144 | NOS3 expression enhancer | 0.144 0.079 DBMET03680 | DBMET03680 | |
| 0.011 | 0.871 | 0.214 | Platelet adhesion inhibitor | 0.214 0.064 DBMET03680 | DBMET03680 | |
| 0.007 | 0.908 | 0.508 | Cyclophilin D inhibitor | 0.508 0.048 DBMET03680 | DBMET03680 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |